Condition
Invasive Mammary Carcinoma
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Recruiting2
Terminated1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07555210Not ApplicableRecruiting
Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
NCT05693766Phase 2RecruitingPrimary
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
NCT04088435Terminated
Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast Cancer
Showing all 3 trials